OMERS ADMINISTRATION Corp
Position in CRL — Charles River Laboratories International, Inc.
CIK 1053321
TORONTO, A6
Position in CRL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,389,002
-$2,286,362 QoQ
Shares Held
54,429
-7.0% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OMERS ADMINISTRATION Corp holds $118,030,675 across 12 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
151,625 | $76,018,710 | |
| 2 | DHR |
Danaher Corp /De/
|
61,949 | $11,800,045 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
13,373 | $7,040,082 | |
| 4 | ILMN |
Illumina, Inc.
|
28,992 | $5,097,663 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
3,573 | $4,564,543 | |
| 6 | NTRA |
Natera, Inc.
|
12,821 | $3,480,260 | |
| 7 | A |
Agilent Technologies, Inc.
|
16,716 | $2,220,386 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
4,030 | $2,134,247 |
All Filings in CRL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,389,002 | 54,429 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,675,364 | 58,529 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,905,767 | 50,529 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,666,765 | 50,529 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,605,625 | 50,529 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,383,771 | 50,833 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,942,257 | 50,476 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,989,688 | 38,676 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||